{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T21:48:14Z","timestamp":1793828894309,"version":"4.6.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T00:00:00Z","timestamp":1663804800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T00:00:00Z","timestamp":1663804800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100006781","name":"Giovanni Armenise-Harvard Foundation","doi-asserted-by":"publisher","award":["CDA"],"award-info":[{"award-number":["CDA"]}],"id":[{"id":"10.13039\/100006781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["COVID-2020-12371849"],"award-info":[{"award-number":["COVID-2020-12371849"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["Ricerca Corrente 2021"],"award-info":[{"award-number":["Ricerca Corrente 2021"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["Ricerca Corrente"],"award-info":[{"award-number":["Ricerca Corrente"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["No. 75N93021C00016"],"award-info":[{"award-number":["No. 75N93021C00016"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Immunol"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1038\/s41590-022-01313-z","type":"journal-article","created":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T12:12:59Z","timestamp":1663848779000},"page":"1445-1456","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":62,"title":["Memory CD8+ T cell diversity and B cell responses correlate with protection against SARS-CoV-2 following mRNA vaccination"],"prefix":"10.1038","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7008-3727","authenticated-orcid":false,"given":"Nadia","family":"Brasu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines","family":"Elia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaia","family":"Montacchiesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona Aversano","family":"Stabile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6791-7126","authenticated-orcid":false,"given":"Carlo","family":"De Intinis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Fesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katiuscia","family":"Gizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1749-7813","authenticated-orcid":false,"given":"Marco","family":"Macagno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Montone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetta","family":"Mussolin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2209-5966","authenticated-orcid":false,"given":"Alba","family":"Grifoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Faravelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3822-7174","authenticated-orcid":false,"given":"Silvia","family":"Marchese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7818-1804","authenticated-orcid":false,"given":"Federico","family":"Forneris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8754-5123","authenticated-orcid":false,"given":"Raffaele","family":"De Francesco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7013-2250","authenticated-orcid":false,"given":"Alessandro","family":"Sette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7908-8049","authenticated-orcid":false,"given":"Vincenzo","family":"Barnaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonino","family":"Sottile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3542-9571","authenticated-orcid":false,"given":"Anna","family":"Sapino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1694-2401","authenticated-orcid":false,"given":"Luigia","family":"Pace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,22]]},"reference":[{"key":"1313_CR1","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/S0140-6736(20)30679-6","volume":"395","author":"D Fisher","year":"2020","unstructured":"Fisher, D. & Wilder-Smith, A. The global community needs to swiftly ramp up the response to contain COVID-19. Lancet 395, 1109\u20131110 (2020).","journal-title":"Lancet"},{"key":"1313_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s13062-020-00283-2","volume":"15","author":"I Celardo","year":"2020","unstructured":"Celardo, I., Pace, L., Cifaldi, L., Gaudio, C. & Barnaba, V. The immune system view of the coronavirus SARS-CoV-2. Biol. Direct 15, 30 (2020).","journal-title":"Biol. Direct"},{"key":"1313_CR3","doi-asserted-by":"crossref","unstructured":"Thomas, S. J. et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine through 6 months. N. Engl. J. Med. 385, 1761\u20131773 (2021).","DOI":"10.1056\/NEJMoa2110345"},{"key":"1313_CR4","unstructured":"Moderna. Moderna Reports Second Quarter Fiscal Year 2021 Financial Results and Provides Business Updates. Press release (2021)."},{"key":"1313_CR5","doi-asserted-by":"publisher","first-page":"100150","DOI":"10.1016\/j.lanepe.2021.100150","volume":"7","author":"G Regev-Yochay","year":"2021","unstructured":"Regev-Yochay, G. et al. Decreased infectivity following BNT162b2 vaccination: a prospective cohort study in Israel. Lancet Reg. Health Eur. 7, 100150 (2021).","journal-title":"Lancet Reg. Health Eur."},{"key":"1313_CR6","doi-asserted-by":"crossref","unstructured":"Baden, L.R. et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N. Engl. J. Med. 384, 403\u2013416 (2021).","DOI":"10.1056\/NEJMoa2035389"},{"key":"1313_CR7","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","volume":"383","author":"FP Polack","year":"2020","unstructured":"Polack, F. P. et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N. Engl. J. Med. 383, 2603\u20132615 (2020).","journal-title":"N. Engl. J. Med."},{"key":"1313_CR8","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1126\/science.abj4176","volume":"373","author":"A Pegu","year":"2021","unstructured":"Pegu, A. et al. Durability of mRNA-1273 vaccine-induced antibodies against SARS-CoV-2 variants. Science 373, 1372\u20131377 (2021).","journal-title":"Science"},{"key":"1313_CR9","doi-asserted-by":"crossref","unstructured":"Altmann, D. M. & Boyton, R. J. SARS-CoV-2 T cell immunity: specificity, function, durability, and role in protection. Sci. Immunol. 5, eabd6160 (2020).","DOI":"10.1126\/sciimmunol.abd6160"},{"key":"1313_CR10","doi-asserted-by":"publisher","first-page":"11034","DOI":"10.1128\/JVI.01505-14","volume":"88","author":"R Channappanavar","year":"2014","unstructured":"Channappanavar, R., Fett, C., Zhao, J., Meyerholz, D. K. & Perlman, S. Virus-specific memory CD8 T cells provide substantial protection from lethal severe acute respiratory syndrome coronavirus infection. J. Virol. 88, 11034\u201311044 (2014).","journal-title":"J. Virol."},{"key":"1313_CR11","doi-asserted-by":"crossref","unstructured":"Gallais, F. et al. Intrafamilial exposure to SARS-CoV-2 associated with cellular immune response without seroconversion, France. Emerg. Infect. Dis. 27, 113\u2013121 (2021).","DOI":"10.3201\/eid2701.203611"},{"key":"1313_CR12","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1016\/j.cell.2022.03.024","volume":"185","author":"A Chandrashekar","year":"2022","unstructured":"Chandrashekar, A. et al. Vaccine protection against the SARS-CoV-2 omicron variant in macaques. Cell 185, 1549\u20131555e1511 (2022).","journal-title":"Cell"},{"key":"1313_CR13","doi-asserted-by":"publisher","first-page":"100861","DOI":"10.1016\/j.eclinm.2021.100861","volume":"35","author":"LJ Abu-Raddad","year":"2021","unstructured":"Abu-Raddad, L. J. et al. SARS-CoV-2 antibody-positivity protects against reinfection for at least seven months with 95% efficacy. eClinicalMedicine 35, 100861 (2021).","journal-title":"eClinicalMedicine"},{"key":"1313_CR14","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1016\/S0140-6736(21)00675-9","volume":"397","author":"VJ Hall","year":"2021","unstructured":"Hall, V. J. et al. SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN). Lancet 397, 1459\u20131469 (2021).","journal-title":"Lancet"},{"key":"1313_CR15","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1056\/NEJMoa2034545","volume":"384","author":"SF Lumley","year":"2021","unstructured":"Lumley, S. F. et al. Antibody status and incidence of SARS-CoV-2 infection in health care workers. N. Engl. J. Med. 384, 533\u2013540 (2021).","journal-title":"N. Engl. J. Med."},{"key":"1313_CR16","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1056\/NEJMoa2110475","volume":"385","author":"N Barda","year":"2021","unstructured":"Barda, N. et al. Safety of the BNT162b2 mRNA Covid-19 vaccine in a nationwide setting. N. Engl. J. Med. 385, 1078\u20131090 (2021).","journal-title":"N. Engl. J. Med."},{"key":"1313_CR17","doi-asserted-by":"crossref","unstructured":"Schmidt, F. et al. High genetic barrier to SARS-CoV-2 polyclonal neutralizing antibody escape. Nature 600, 512\u2013516 (2021).","DOI":"10.1038\/s41586-021-04005-0"},{"key":"1313_CR18","doi-asserted-by":"crossref","unstructured":"Stamatatos, L. et al. mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection. Science 372, 1413\u20131418 (2021).","DOI":"10.1126\/science.abg9175"},{"key":"1313_CR19","doi-asserted-by":"crossref","unstructured":"Rodda, L. B. et al. Imprinted SARS-CoV-2-specific memory lymphocytes define hybrid immunity. Cell 185, 1588\u20131601.e14 (2022).","DOI":"10.1016\/j.cell.2022.03.018"},{"key":"1313_CR20","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/s41586-021-03207-w","volume":"591","author":"C Gaebler","year":"2021","unstructured":"Gaebler, C. et al. Evolution of antibody immunity to SARS-CoV-2. Nature 591, 639\u2013644 (2021).","journal-title":"Nature"},{"key":"1313_CR21","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/s41586-021-03696-9","volume":"595","author":"Z Wang","year":"2021","unstructured":"Wang, Z. et al. Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection. Nature 595, 426\u2013431 (2021).","journal-title":"Nature"},{"key":"1313_CR22","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1056\/NEJMoa2028436","volume":"383","author":"EJ Anderson","year":"2020","unstructured":"Anderson, E. J. et al. Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 vaccine in older adults. N. Engl. J. Med. 383, 2427\u20132438 (2020).","journal-title":"N. Engl. J. Med."},{"key":"1313_CR23","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/s41586-020-2814-7","volume":"586","author":"U Sahin","year":"2020","unstructured":"Sahin, U. et al. COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses. Nature 586, 594\u2013599 (2020).","journal-title":"Nature"},{"key":"1313_CR24","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/j.immuni.2020.11.009","volume":"53","author":"K Lederer","year":"2020","unstructured":"Lederer, K. et al. SARS-CoV-2 mRNA vaccines foster potent antigen-specific germinal center responses associated with neutralizing antibody generation. Immunity 53, 1281\u20131295.e1285 (2020).","journal-title":"Immunity"},{"key":"1313_CR25","doi-asserted-by":"crossref","unstructured":"Pace, L. Temporal and epigenetic control of plasticity and fate decision during CD8+ T-cell memory differentiation. Cold Spring Harb. Perspect. Biol. 13, a037754 (2021).","DOI":"10.1101\/cshperspect.a037754"},{"key":"1313_CR26","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.immuni.2020.12.009","volume":"54","author":"NN Jarjour","year":"2021","unstructured":"Jarjour, N. N., Masopust, D. & Jameson, S. C. T cell memory: understanding COVID-19. Immunity 54, 14\u201318 (2021).","journal-title":"Immunity"},{"key":"1313_CR27","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.immuni.2018.02.010","volume":"48","author":"SC Jameson","year":"2018","unstructured":"Jameson, S. C. & Masopust, D. Understanding subset diversity in T cell memory. Immunity 48, 214\u2013226 (2018).","journal-title":"Immunity"},{"key":"1313_CR28","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.cell.2022.01.015","volume":"185","author":"A Tarke","year":"2022","unstructured":"Tarke, A. et al. SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from alpha to omicron. Cell 185, 847\u2013859.e811 (2022).","journal-title":"Cell"},{"key":"1313_CR29","doi-asserted-by":"publisher","first-page":"eabj9853","DOI":"10.1126\/science.abj9853","volume":"374","author":"J Mateus","year":"2021","unstructured":"Mateus, J. et al. Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells. Science 374, eabj9853 (2021).","journal-title":"Science"},{"key":"1313_CR30","unstructured":"Goel, R. R. et al. mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern. Science 374, eabm0829 (2021)."},{"key":"1313_CR31","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41586-021-04385-3","volume":"602","author":"Y Cao","year":"2022","unstructured":"Cao, Y. et al. Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies. Nature 602, 657\u2013663 (2022).","journal-title":"Nature"},{"key":"1313_CR32","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/s41586-021-04387-1","volume":"602","author":"S Cele","year":"2022","unstructured":"Cele, S. et al. Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization. Nature 602, 654\u2013656 (2022).","journal-title":"Nature"},{"key":"1313_CR33","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.chom.2021.05.010","volume":"29","author":"A Grifoni","year":"2021","unstructured":"Grifoni, A. et al. SARS-CoV-2 human T cell epitopes: aaptive immune response against COVID-19. Cell Host Microbe 29, 1076\u20131092 (2021).","journal-title":"Cell Host Microbe"},{"key":"1313_CR34","doi-asserted-by":"publisher","first-page":"4112","DOI":"10.4049\/jimmunol.178.7.4112","volume":"178","author":"P Romero","year":"2007","unstructured":"Romero, P. et al. Four functionally distinct populations of human effector-memory CD8+ T lymphocytes. J. Immunol. 178, 4112\u20134119 (2007).","journal-title":"J. Immunol."},{"key":"1313_CR35","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/44385","volume":"401","author":"F Sallusto","year":"1999","unstructured":"Sallusto, F., Lenig, D., Forster, R., Lipp, M. & Lanzavecchia, A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401, 708\u2013712 (1999).","journal-title":"Nature"},{"key":"1313_CR36","doi-asserted-by":"crossref","unstructured":"Mathew, D. et al. Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications. Science 369, eabc8511 (2020).","DOI":"10.1126\/science.369.6508.1203-l"},{"key":"1313_CR37","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.immuni.2022.02.004","volume":"55","author":"JR Giles","year":"2022","unstructured":"Giles, J. R. et al. Human epigenetic and transcriptional T cell differentiation atlas for identifying functional T cell-specific enhancers. Immunity 55, 557\u2013574.e557 (2022).","journal-title":"Immunity"},{"key":"1313_CR38","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2598-9","volume":"587","author":"J Braun","year":"2020","unstructured":"Braun, J. et al. SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19. Nature 587, 270\u2013274 (2020).","journal-title":"Nature"},{"key":"1313_CR39","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1016\/j.cell.2020.05.015","volume":"181","author":"A Grifoni","year":"2020","unstructured":"Grifoni, A. et al. Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals. Cell 181, 1489\u20131501.e1415 (2020).","journal-title":"Cell"},{"key":"1313_CR40","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.cell.2020.08.017","volume":"183","author":"T Sekine","year":"2020","unstructured":"Sekine, T. et al. Robust T cell immunity in convalescent Individuals with asymptomatic or mild COVID-19. Cell 183, 158\u2013168.e114 (2020).","journal-title":"Cell"},{"key":"1313_CR41","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41586-021-03841-4","volume":"597","author":"V Oberhardt","year":"2021","unstructured":"Oberhardt, V. et al. Rapid and stable mobilization of CD8+ T cells by SARS-CoV-2 mRNA vaccine. Nature 597, 268\u2013273 (2021).","journal-title":"Nature"},{"key":"1313_CR42","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","volume":"581","author":"J Lan","year":"2020","unstructured":"Lan, J. et al. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature 581, 215\u2013220 (2020).","journal-title":"Nature"},{"key":"1313_CR43","doi-asserted-by":"publisher","first-page":"eabo2202","DOI":"10.1126\/sciimmunol.abo2202","volume":"7","author":"CH GeurtsvanKessel","year":"2022","unstructured":"GeurtsvanKessel, C. H. et al. Divergent SARS-CoV-2 omicron-reactive T and B cell responses in COVID-19 vaccine recipients. Sci. Immunol. 7, eabo2202 (2022).","journal-title":"Sci. Immunol."},{"key":"1313_CR44","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/s41586-022-04460-3","volume":"603","author":"R Keeton","year":"2022","unstructured":"Keeton, R. et al. T cell responses to SARS-CoV-2 spike cross-recognize omicron. Nature 603, 488\u2013492 (2022).","journal-title":"Nature"},{"key":"1313_CR45","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1126\/science.abd3871","volume":"370","author":"J Mateus","year":"2020","unstructured":"Mateus, J. et al. Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans. Science 370, 89\u201394 (2020).","journal-title":"Science"},{"key":"1313_CR46","doi-asserted-by":"crossref","first-page":"6681","DOI":"10.4049\/jimmunol.162.11.6681","volume":"162","author":"P Scognamiglio","year":"1999","unstructured":"Scognamiglio, P. et al. Presence of effector CD8+ T cells in hepatitis C virus-exposed healthy seronegative donors. J. Immunol. 162, 6681\u20136689 (1999).","journal-title":"J. Immunol."},{"key":"1313_CR47","doi-asserted-by":"crossref","unstructured":"Swadling, L. et al. Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2. Nature 601, 110\u2013117 (2021).","DOI":"10.1101\/2021.06.26.21259239"},{"key":"1313_CR48","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/s41586-020-03041-6","volume":"590","author":"K McMahan","year":"2021","unstructured":"McMahan, K. et al. Correlates of protection against SARS-CoV-2 in rhesus macaques. Nature 590, 630\u2013634 (2021).","journal-title":"Nature"},{"key":"1313_CR49","doi-asserted-by":"crossref","unstructured":"Shapiro, J. R. et al. Association of frailty, age, and biological sex with SARS-CoV-2 mRNA vaccine-induced immunity in older adults. Clin. Infect. Dis. 75(Suppl. 1), S61\u2013S71 (2022).","DOI":"10.1101\/2022.03.11.22272269"},{"key":"1313_CR50","doi-asserted-by":"publisher","first-page":"786586","DOI":"10.3389\/fimmu.2022.786586","volume":"13","author":"J Bai","year":"2022","unstructured":"Bai, J. et al. Sex, age, and ethnic background shape adaptive immune responses induced by the SARS-CoV-2 mRNA vaccine. Front. Immunol. 13, 786586 (2022).","journal-title":"Front. Immunol."}],"container-title":["Nature Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41590-022-01313-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-022-01313-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-022-01313-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,19]],"date-time":"2023-02-19T22:14:41Z","timestamp":1676844881000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41590-022-01313-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,22]]},"references-count":50,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["1313"],"URL":"https:\/\/doi.org\/10.1038\/s41590-022-01313-z","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.742368035.793596012","asserted-by":"object"}]},"ISSN":["1529-2908","1529-2916"],"issn-type":[{"value":"1529-2908","type":"print"},{"value":"1529-2916","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,22]]},"assertion":[{"value":"18 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.Sette is a consultant for Gritstone Bio, Flow Pharma, Arcturus Therapeutics, ImmunoScape, CellCarta, Avalia, Moderna, Fortress and Repertoire. All other authors declare no conflicts of interest. L.J.I. has filed for patent protection for various aspects of T cell epitope and vaccine design work. CCI. has filed a patent for immune correlate of protection after RNA vaccination. R.D.F. is a consultant for Moderna Inc. The data are tabulated in the main paper and in the supplementary materials.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}